Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
ARTICLE

Activation of Caspase-3 in the Retina of Transgenic Rats with the Rhodopsin Mutation S334ter during Photoreceptor Degeneration

Changdong Liu, Yiwen Li, Min Peng, Alan M. Laties and Rong Wen
Journal of Neuroscience 15 June 1999, 19 (12) 4778-4785; DOI: https://doi.org/10.1523/JNEUROSCI.19-12-04778.1999
Changdong Liu
1Departments of Ophthalmology,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yiwen Li
2Neurology, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Min Peng
1Departments of Ophthalmology,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan M. Laties
1Departments of Ophthalmology,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rong Wen
1Departments of Ophthalmology,
3Cell and Developmental Biology, University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania 19104
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The role of caspase-3 in photoreceptor degeneration was examined in a line of transgenic rats that carry a rhodopsin mutation S334ter. Photoreceptor degeneration in these animals is rapid. It is detected as early as postnatal day (PD) 8, and by PD 20, only one of the original 12 rows of nuclei remain in the outer nuclear layer. At PD 11 and 12, the number of photoreceptors dying per day reaches a peak of ∼30% of the total photoreceptors in the retina. Coincident with this rapid degeneration is an increase in caspase-3-like activity as assessed by the cleavage of a fluorescent substrateN-acetyl-Asp-Glu-Val-Asp-aminomethylcoumarin and an increase in activated caspase-3 as determined by Western blot analysis for its 12 kDa subunit. Intraocular injection of an irreversible caspase-3 inhibitorN-benzyloxycarbonal-Asp(OMe)-Glu(OMe)-Val-Asp(Ome)-fluoromethyketone partially protected photoreceptors from degeneration. These findings indicate that a caspase-3-dependent mechanism is operative in photoreceptor death in the transgenic rats under investigation.

  • caspase-3
  • photoreceptors
  • z-DEVD-fmk
  • rhodopsin mutation
  • degeneration
  • retina
  • transgenic rat

Inherited retinal degenerations, collectively known as retinitis pigmentosa, are characterized by progressive death of photoreceptors. Mutations in any of a number of photoreceptor-specific proteins, including rhodopsin (Dryja et al., 1990a,b; Farrar et al., 1990), peripherin (Travis et al., 1989; Farrar et al., 1991; Kajiwara et al., 1991), the β subunit of the cGMP phosphodiesterase (Bowes et al., 1990; McLaughlin et al., 1993, 1995), and a rod outer segment protein, ROM1 (Kajiwara et al., 1994), can lead to photoreceptor degeneration. Moreover, introduction of mutant rhodopsin genes into the genomes of mouse (Olsson et al., 1992), pig (Petters et al., 1997), or rat (Steinberg et al., 1996, 1997) has successfully mimicked the phenotypes of retinitis pigmentosa as observed in humans.

Photoreceptor cell death in animal models is considered an apoptotic process, because DNA fragmentation has been demonstrated in degenerating photoreceptors (Chang et al., 1993; Portera-Cailliau et al., 1994). Since apoptosis, or programmed cell death, was originally shown to be a cell suicide process with distinct morphological characteristics (Wyllie, 1987), enormous progress has been made in unraveling the components of the death mechanism. Pioneering studies performed on the nematode Caenorhabditis elegans identified a complement of genes related to cell death, including ced-3, ced-4, and ced-9. The first identified mammalian homolog of CED-3 was the interleukin-1 β-converting enzyme (ICE) (Yuan et al., 1993). In turn, a search for ICE-related proteins revealed an entire family of proteases in mammals. These comprise at least 12 members termed caspases (for cysteine-containing, aspartate-specific proteases) (Thornberry and Lazebnik, 1998). Among them, activation of caspase-3 has been shown to participate in the initiation of apoptosis (Thornberry and Lazebnik, 1998), especially in neurons (Kuida et al., 1996; Armstrong et al., 1997; Yakovlev et al., 1997; Cheng et al., 1998; Namura et al., 1998).

In the present work, we examine the activation of caspase-3 in a line of transgenic rats that carry the rhodopsin mutation S334ter. Photoreceptors in these animals undergo rapid degeneration: >50% of photoreceptors die in just 2 d, postnatal days (PD) 11 and 12. There is a significant increase in caspase-3 activation during the rapid phase of photoreceptor degeneration. Furthermore, intraocular administration of specific peptide active-site inhibitor of caspase-3 inhibits photoreceptor degeneration. These results indicate that a caspase-3-dependent mechanism plays an important role in the demise of photoreceptors.

MATERIALS AND METHODS

Transgenic animals and intraocular injections.Homozygous breeders of line 3 of transgenic rats that carry a murine rhodopsin mutant S334ter (S334ter-3) were kindly provided by Dr. M. M. LaVail (University of California, San Francisco, CA). Heterozygous S334ter-3 rats were produced by mating homozygous breeders with wild-type Sprague Dawley rats. All experiments were performed using heterozygous S334ter-3 rats. Controls were age-matched Sprague Dawley rats. Animals were kept in a 12 hr light/dark cycle at an in-cage illuminance of <10 foot-candles (1 foot-candle = 10.76 lux). The in-cage temperature was kept at 20–22°C. Intraocular injections were given directly into the vitreous by 32 gauge needles. The caspase-3 inhibitorN-benzyloxycarbonal-Asp(OMe)-Glu(OMe)-Val-Asp(Ome)-fluoromethyketone (z-DEVD-fmk) was purchased from Enzyme Systems Products (Dublin, CA).

Histology and Terminal dUTP Nick End Labeling. Animals were killed by CO2 overdose, immediately followed by vascular perfusion with mixed aldehydes (LaVail and Battelle, 1975). Eyes were embedded in an Epon-Araldite mixture and sectioned at 1 μm thickness to display the entire retina along the vertical meridian (LaVail and Battelle, 1975). Retinal sections were examined by light microscopy. Twenty-seven transgenic animals from three litters were used for experiments described in Figure 1. Twelve wild-type Sprague Dawley rats were used for experiments described in Figure 2. The terminal dUTP nick end-labeling (TUNEL) method (Gavrieli et al., 1992) was used to detect DNA fragmentation. Eyes were removed from 4% paraformaldehyde-perfused animals (three transgenic and three control rats), cryoprotected with 20% sucrose, frozen in Tissue-Tek OCT compound (Miles, Elkhart, IN) in powdered dry ice, and stored at −80°C. Cryosections of 10 μm were cut through the entire retina along the vertical meridian and thaw-mounted onto Super Frost Plus glass slides (Fisher Scientific, Pittsburgh, PA). TUNEL was performed using an apoptosis detection system (Promega, Madison, WI) according to the manufacturer’s instructions.

Measurement of caspase activities. Retinas were dissected, snap-frozen in powdered dry ice, and stored at −80°C. Total protein was obtained by homogenizing retinas in a lysis buffer that contained 100 mm HEPES, pH 7.5, 10% sucrose, 1 mm EDTA, 20 mm EGTA, 0.2% 3[3-cholamidopropyl)dimethylammonio]-1-propane-sulfonate, 10 mm dithiothreitol, 10 μg of leupeptin, 2 μg/ml pepstatin, 2 μg/ml aprotinin, 1 mm PMSF, and 0.03% digitonin. The amount of total protein of each sample was determined by the BCA protein assay (Pierce, Rockford, IL), and the samples were stored at −80°C. Caspase-3 or caspase-1 activity was assessed by measuring the cleavage of fluorogenic substrate Ac-DEVD-AMC or Ac-YVAD-AMC, respectively, using a luminescence spectrometer (LS-50B; Perkin-Elmer, Norwalk, CT). Cleavage ofN-acetyl-Asp-Glu-Val-Asp-aminomethylcoumarin (Ac-DEVD-AMC) or N-acetyl-Tyr-Val-Ala-Asp-aminomethylcoumarin (Ac-YVAD-AMC) was measured for 900 sec for each sample of 100 μg of total protein (accumulation of fluorescence was linear for at least 2 hr). The rate of fluorescence accumulation was calculated as the activity of a given enzyme. Experiments were repeated three times with samples from three litters of transgenic or control animals.

Protein preparation and immunoblotting analysis. Retinas were dissected, snap-frozen in powdered dry ice, and stored at −80°C. Pooled retinas were homogenized, and the concentration of total protein in each sample was determined by the BCA protein assay (Pierce). Total protein of 100 μg from each sample was electrophoresed on polyacrylamide gels and transferred to nitrocellular membranes (Bio-Rad, Hercules, CA). Blots were stained briefly with Ponceau S for visual inspection of transfer efficiency. Immunoblotting analysis was performed using polyclonal antibodies against the 12 kDa subunit of the active form of caspase-3 (Santa Cruz Biotechnology, Santa Cruz, CA). Signals were visualized using an ECL kit (Amersham, Arlington Heights, IL) and recorded on Hyperfilm (Amersham). All experiments were repeated three times to verify the consistency of the results.

RESULTS

Photoreceptor degeneration in heterozygous transgenic rats

The progressive photoreceptor degeneration in the retinas of heterozygous S334ter-3 rats follows a pattern described by M. M. LaVail (personal communication). Figure1 shows representative light micrographs of heterozygous S334ter-3 rat retinas from PD 6 to 20. The overall appearance of the retina of a transgenic animal at PD 6 (Fig.1A) is similar to an age-matched control (Fig.2A), differing slightly in stage of postnatal development. However, in the retina of a PD 8 S334ter-3 rat, 30–50 pyknotic nuclei in the outer nuclear layer (ONL) are found in an entire retinal section (Fig. 1B), in contrast to only one or two in the control ONL (data not shown). By PD 10, the retina of the transgenic rats differs greatly from that of control: not only are many pyknotic nuclei found in the ONL in the transgenic rats, but the inner segments of photoreceptors are now disorganized (Fig. 1C). Substantial loss of photoreceptors occurs at PD 11 (Fig. 1D). By PD 12, the ONL contains only six or seven rows of nuclei, in contrast to 12–13 rows in normal controls (Fig. 2C). The inner segments are even more disorganized (Fig. 1E). By PD 14, the rows of nuclei in the ONL decreased to three or four in the S334ter-3 rats, and the remaining inner segments are now short stumps (Fig.1F). The nuclei in the ONL further decline to two or three rows at PD 16. Only one row remains at PD 20 with residual inner segments (Fig. 1G–I). No outer segments ever develop in the heterozygous S334ter-3 rats.

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.

Photoreceptor degeneration in the S334ter-3 rats. Plastic-embedded sections of retinas from S334ter-3 rats of PD 6 (A), 8 (B), 10 (C), 11 (D), 12 (E), 14 (F), 16 (G), 18 (H), and 20 (I) were examined by light microscopy (superior region). The ONL is indicated in each panel by a white bar. Pyknotic nuclei in B and Care indicated by white arrowheads. Loss of photoreceptors becomes evident at PD 8. Peak of photoreceptor death occurs at PD 11 and 12. Pyknotic nuclei are found mainly in the proximal half of the ONL at PD 8 (B), 10 (C), and 11 (D). Some photoreceptor nuclei are displaced to the subretinal space (B–E). Sections were stained with toluidine blue. Scale bar, 20 μm.

Fig. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.

Photoreceptors in normal Sprague Dawley rats during postnatal development. Plastic-embedded sections of retinas from Sprague Dawley rats of PD 6 (A), 8 (B), 10 (C), 12 (D), 16 (E), and 20 (F) were examined by light microscopy (superior region). The ONL is indicated in each panel by a white bar. Development of rod outer segments is evident at PD 10 (C). Rod outer segments are approximately half of the length of those in the mature retina by PD 12 (D). Photoreceptors in PD 16 (E) and 20 (F) animals resemble closely those found in mature animals. Sections were stained with toluidine blue. Scale bar, 20 μm.

In the early stages of photoreceptor degeneration in the S334ter-3 rats (PD 8–11), pyknotic nuclei are distributed mainly in the proximal half of the ONL (Fig. 1B–D). As the degeneration progresses, they are seen in the distal ONL as well (Fig.1D,E).

During degeneration, some photoreceptor nuclei become dislocated to the subretinal space next to the retinal pigment epithelial (RPE) cells (Fig. 1B–E). No such dislocation is observed in control animals (Fig. 2).

For comparison, Figure 2 shows representative light micrographs of normal Sprague Dawley rat retinas from PD 6 to 20. At PD 6, the overall morphological appearance of Sprague Dawley retina (Fig.2A) is similar to that of the transgenic rats (Fig.1A). At PD 8, the ONL (Fig. 2B) thickens, and the inner segments are well organized (Fig.2B). By PD 10, the outer segments of rod photoreceptors begin to develop (Fig. 2C). At PD 10, the rod outer segments are approximately half of the length of those in mature retina (Fig. 2D). Photoreceptors in PD 16 (Fig.2E) and 20 (Fig. 2F) animals are similar to those found in mature normal animals. Only one or two pyknotic nuclei are observed in the ONL from PD 10 through 20 (data not shown).

To determine whether photoreceptor death in the S334ter-3 rats was apoptotic, we used the TUNEL method (Gavrieli et al., 1992) to detect DNA fragmentation. As shown in Figure 3, many cells in the ONL of a PD 11 transgenic rat are TUNEL-positive. The distribution of TUNEL-labeled cells is denser in the proximal than in the distal ONL (Fig. 3A). This is consistent with the distribution of pyknotic nuclei (Fig. 1D). In age-matched control animals (Fig. 3B), no TUNEL-labeled cells are found in the ONL. In the inner nuclear layer (INL), a few cells are TUNEL-positive in both control (Fig. 3B) and transgenic (Fig. 3A) animals.

Fig. 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 3.

DNA fragmentation in degenerating photoreceptors of the S334ter-3 rats. Cryosections (10 μm) from the retina of a PD 11 S334ter-3 (A) and a wild-type Sprague Dawley rat (B) were TUNEL-labeled with fluorescein to visualize the DNA fragmentation. In the S334ter-3 rat (A), numerous cells in the ONL are labeled. The distribution of labeled cells is denser in the proximal than in the distal ONL. No labeled cells are found in the ONL of the control retina (B). A few cells in the INL are also labeled in the control (B) and transgenic (A) rats. rpe, Retinal pigment epithelium; onl, outer nuclear layer;inl, inner nuclear layer; gc, ganglion cell layer. Scale bar, 50 μm.

Activation of caspase-3 in the S334ter-3 rat retina during degeneration

The activity of caspase-3-like proteases was assessed by measuring the cleavage of a fluorogenic substrate Ac-DEVD-AMC. Retinal samples were collected from transgenic and age-matched Sprague Dawley control animals at PD 8–14 and 16. A large increase in Ac-DEVD-AMC cleavage was observed in transgenic animals at PD 11–14. It was close to sixfold of control level at PD 11 and 12 and declined to approximately twofold at PD 13 and 14 (Fig.4A). Because Ac-DEVD-AMC is also cleaved by caspase-1, we ruled out this possibility by using a caspase-1-specific fluorogenic substrate, Ac-YVAD-AMC. Substrates with a sequence of YVAD, based on the recognition sequence for caspase-1 YVHD, have high selectivity for caspase-1 over caspase-3. In fact, the tetrapeptide aldehyde Ac-YVAD-CHO is highly selective, possessing an affinity for caspase-1 six orders of magnitude higher than for caspase-3 (Fernandes-Alnemri et al., 1995; Margolin et al., 1997). As shown in Figure 4B, no significant alteration in Ac-YVAD-AMC cleavage was observed from PD 8 to 16 in the S334ter-3 rats, compared with the controls, indicating that caspase-1 is not significantly activated during photoreceptor degeneration.

Fig. 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 4.

Activities of caspase-3-like and caspase-1-like proteases in the retina. Activities of caspase-3-like or caspase-1-like proteases were determined by measuring the cleavage of Ac-DEVD-AMC or Ac-YVAD-AMC, respectively. Retinas were collected at PD 8–14 and 16 from S334ter-3 or normal Sprague Dawley rats. Intensity of fluorescence was measured on a Perkin-Elmer LS-50B luminescence spectrometer at 30 sec intervals for 900 sec. The rate of accumulation of fluorescence was calculated as the activity of a given enzyme. Data are presented as mean ± SD (n = 3). ***p< 0.001; *p < 0.01 (Student’s ttest).

Caspases-3 is synthesized as a 32 kDa inactive proenzyme and is cleaved at Asp-28-Ser-29 and Asp-175-Ser-176 to generate a subunit of 17 kDa and a smaller one of 12 kDa after activation (Nicholson et al., 1995). To assess the amount of active caspase-3 during photoreceptor degeneration, we measured the amount of the 12 kDa subunit in retinas of the S334ter-3 rats by immunoblotting analysis. Figure5A displays the relative amounts of the 12 kDa subunit during photoreceptor degeneration. Significant increases were found at PD 10–12 in the transgenic rats, coincident with the rapid phase of photoreceptor loss in the retina. The amounts of the 12 kDa subunit in the transgenic rats during the rapid degeneration phase are much higher than those in the age-matched Sprague Dawley control rats (Fig. 5B).

Fig. 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 5.

p12 subunit of activated caspase-3 during photoreceptor degeneration in the S334ter-3 rats. Immunoblotting analyses were performed to detect the p12 subunit of the active form of caspase-3, using polyclonal antibodies against the p12 subunit of caspase-3. A, In the retinas of S334ter-3 rats, significant increases in the p12 subunit are found at PD 10–12, which coincides with the rapid degeneration phase. B, The amounts of the 12 kDa subunit in the retina of PD 10 (P10) and 12 (P12) S334ter-3 animals (Tg) are significantly higher than age-matched Sprague Dawley rats (SD).

Protection of photoreceptors by peptide caspase inhibitor z-DEVD-fmk

To test whether caspase-3 is important for photoreceptor death in the S334ter-3 rats, we used an irreversible inhibitor for caspase-3, z-DEVD-fmk. Six S334ter-3 rats (littermates) were injected at PD 9 with 50 μg of z-DEVD-fmk (in 1 μl of DMSO) into the left eyes and 1 μl of DMSO into the right eyes. The eyes were collected at PD 20, and retinas were examined by light microscopy. As shown in Figure6, the retina of a PD 20 normal animal is fully developed and intact. The ONL contains 12–13 rows of nuclei, and the outer and inner segments are well organized (Fig.6A). The retina of a S334ter-3 rat treated with DMSO (Fig. 6B) corresponds to those without any treatment (Fig. 1I): only a single row of nuclei remain in the ONL (Fig. 6B). In contrast, the ONL of the z-DEVD-fmk-treated retina from the other eye of the same animal contains four or five rows of nuclei (Fig. 6A). In all six animals, the ONL in the control eyes has one or two rows of nuclei, whereas the treated eyes have three to five rows.

Fig. 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 6.

Protection of photoreceptors by z-DEVD-fmk. Plastic-embedded sections of retinas from a normal rat (A) and a S334ter-3 rat treated with DMSO (B) or z-DEVD-fmk (C) at PD 20 were examined by light microscopy. The normal retina has well developed outer and inner segments. The ONL has 12 or 13 rows of nuclei (A). In the DMSO-treated retina, the ONL has only one row of nuclei, and inner segments become short stumps (B). In the z-DEVD-fmk-treated retina from the same animal (C), the ONL has four or five rows of nuclei. The inner segments are better preserved, although still shortened and disorganized. Some dislocated cells are found in the subretinal space next to the RPE. Sections were stained with toluidine blue. OS, Outer segment; IS, inner segment; OPL, outer plexiform layer. Scale bar, 20 μm.

To verify that z-DEVD-fmk did inhibit caspase-3 activation in the retinas of S334ter-3 rats, we measured the 12 kDa caspase-3 subunit after inhibitor injection. Three transgenic rats were injected with 50 μg of z-DEVD-fmk (in 1 μl of DMSO) into the left eyes and 1 μl of DMSO into the right eyes at PD 9, and retinas were collected at PD 11. As shown in Figure 7, the amount of the 12 kDa subunit in retinas treated with z-DEVD-fmk is significantly lower than in those treated only with DMSO. Nevertheless, it is still higher than in the normal Sprague Dawley rats.

Fig. 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 7.

The p12 subunit of activated caspase-3 after intraocular injection of caspase-3 inhibitor z-DEVD-fmk. PD 9 S334ter-3 rats were injected with 50 μg of z-DEVD-fmk (in 1 μl of DMSO) to the left eyes and 1 μl of vehicle (DMSO) to the right eyes. Retinas were collected at PD 11. Retinas of age-matched Sprague Dawley rats served as control. Immunoblotting analyses were performed to detect the p12 subunit of the active form of caspase-3, using polyclonal antibodies against the p12 subunit of caspase-3. In the S334ter-3 rats, the amount of the p12 subunit is much less in inhibitor treated retinas (Tg, Ihb +) than in vehicle-treated retinas (Tg, Ihb −), although it is still higher than normal Sprague Dawley controls (SD, Ihb −).

DISCUSSION

Since the discovery of mutations in the rhodopsin gene in human with retinitis pigmentosa (Dryja et al., 1990a,b; Farrar et al., 1990), various mutations of the visual pigment have been introduced into the genomes of animals as models of these disorders (Olsson et al., 1992;Steinberg et al., 1996, 1997; Petters et al., 1997). These transgenic animals are valuable tools for retinal degeneration research. In the present work, we used a line of transgenic rats that carry a murine rhodopsin mutation, S334ter (Steinberg et al., 1996, 1997). These animals undergo a degenerative course leading to the death of >90% of all photoreceptors in <2 weeks. At the peak rate of photoreceptor death, the loss of photoreceptors reaches three or four rows of nuclei in the ONL in 1 day, or close to 30% of the photoreceptors in the entire retina (Fig. 1). It is estimated that in the rat retina one row of nuclei in the ONL represents about 1 million photoreceptors. Thus, at the peak of degeneration, the death rate is 3–4 million rods/d. The massive photoreceptor death in these animals provides an opportunity to investigate the biochemistry of photoreceptor degeneration.

Histological analysis shows that photoreceptor degeneration begins at the proximal portion of the ONL, because pyknotic nuclei are found mainly in the proximal half of the ONL from PD 8 through 11 (Fig. 1). In addition, more TUNEL-labeled cells are observed in the proximal than in the distal ONL at PD 11 (Fig. 2). The reason why cells in the proximal ONL are more susceptible to degeneration is not clear. It is possible that these cells are more advanced in development than those in the distal portion of the ONL and therefore die sooner.

The displacement of photoreceptor nuclei to the subretinal space (Fig.1) is likely to be a phenomenon related to the degenerative process, because it is observed only in the retinas of transgenic animals undergoing photoreceptor degeneration.

The first indication that caspases are involved in photoreceptor death derives from Drosophila, in which mutations in the rhodopsin gene also cause photoreceptor degeneration (Steele and O’Tousa, 1990;Colley et al., 1995; Kurada and O’Tousa, 1995). Experiments in two strains of Drosophila with rhodopsin mutations,ninaERH27 andrdgC306, showed that eye-specific expression of baculovirus protein p35 not only protects photoreceptors but also preserves their normal function (Davidson and Steller, 1998). p35 blocks cell death after viral infection and is regarded as antiapoptotic (Friesen and Miller, 1987; Clem et al., 1991). Purified recombinant p35 inhibits a broad range of caspases, including caspase-1, -2, -3, and -4 (Bump et al., 1995; Xue and Horvitz, 1995). The demonstration by Davidson and Steller (1998) that p35 protects photoreceptors indicates that in Drosophila photoreceptor cell death likely is mediated by a caspase-dependent mechanism.

Caspase-3 was first cloned using the sequence of an expressed sequence tag in the sequence database that shared similarity with ICE and was named CPP32 (Fernandes-Alnemri et al., 1994). Subsequently, two other groups independently identified it and named it Yama (Tewari et al., 1995) and apopain (Nicholson et al., 1995). Among known caspases, it has the highest homology to C. elegans CED-3 in both amino acid sequence and substrate specificity. It is recognized as one of the key executioners of apoptosis. Moreover, activation of caspase-3 is important for the initiation of apoptosis in neurons. For instance, in caspase-3 knock-out mice, there is a selective defect in cell death in the CNS that leads to a doubling of brain size (Kuida et al., 1996). This finding indicates that caspase-3 plays a critical role during morphogenetic cell death in the brain. In cultured mouse cerebellar granule neurons, K+-serum withdrawal also activates caspase-3, inducing apoptosis (Armstrong et al., 1997). In addition, caspase-3 is found to contribute to apoptosis in brain neurons after traumatic brain injury or experimental cerebral ischemia (Yakovlev et al., 1997; Cheng et al., 1998; Namura et al., 1998). Last, in the retina caspase-3 is involved in ganglion cell death after optic nerve transection (Kermer et al., 1998).

The present work establishes a role of caspase-3 in the photoreceptor degeneration in S334ter-3 rats. A clear relationship among the increase in Ac-DEVD-AMC cleavage, the increase in the 12 kDa subunit of caspase-3, and the course of photoreceptor degeneration indicates a correlation between caspase-3 activation and photoreceptor degeneration. That inhibition of caspase-3 by the irreversible caspase-3 inhibitor z-DEVD-fmk protects photoreceptors provides further evidence that caspase-3 activation promotes the death of photoreceptors.

Our present work leaves unanswered the question of whether photoreceptor death by causes other than rhodopsin mutations is also mediated by the same mechanism. However, preliminary experiments (R. Wen, unpublished observations) do indicate that caspase-3 is involved in photoreceptor death in other animal models as well, suggesting a common mechanism for photoreceptor degeneration in these disorders. Further analysis of the involvement of caspases not only will deepen our understanding of photoreceptor cell death but also might provide the basis for a new approach to therapies for retinal degenerative disorders. The present work represents a step toward that goal.

Footnotes

  • This work was supported by the Foundation Fighting Blindness and a grant from the Paul and Evanina Mackall Foundation Trust. R.W. is a recipient of a Research to Prevent Blindness career development award. We thank Dr. Matthew M. LaVail and Nancy Lawson for homozygous S334ter-3 rats.

    Correspondence should be addressed to Dr. Rong Wen, Department of Ophthalmology, D-603 Richards Building, University of Pennsylvania, School of Medicine, Philadelphia, PA 19104.

REFERENCES

  1. ↵
    1. Armstrong RC,
    2. Aja TJ,
    3. Hoang KD,
    4. Gaur S,
    5. Bai X,
    6. Alnemri ES,
    7. Litwack G,
    8. Karanewsky DS,
    9. Fritz LC,
    10. Tomaselli KJ
    (1997) Activation of the CED3/ICE-related protease CPP32 in cerebellar granule neurons undergoing apoptosis but not necrosis. J Neurosci 17:553–562.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Bowes C,
    2. Li T,
    3. Danciger M,
    4. Baxter LC,
    5. Applebury ML,
    6. Farber DB
    (1990) Retinal degeneration in the rd mouse is caused by a defect in the beta subunit of rod cGMP-phosphodiesterase. Nature 347:677–680.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Bump NJ,
    2. Hackett M,
    3. Hugunin M,
    4. Seshagiri S,
    5. Brady K,
    6. Chen P,
    7. Ferenz C,
    8. Franklin S,
    9. Ghayur T,
    10. Li P,
    11. Licari P,
    12. Mankovich J,
    13. Shi L,
    14. Greenberg AH,
    15. Miller LK,
    16. Wong WW
    (1995) Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science 269:1885–1888.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Chang GQ,
    2. Hao Y,
    3. Wong F
    (1993) Apoptosis: final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neuron 11:595–605.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Cheng Y,
    2. Deshmukh M,
    3. D’Costa A,
    4. Demaro JA,
    5. Gidday JM,
    6. Shah A,
    7. Sun Y,
    8. Jacquin MF,
    9. Johnson EMJ,
    10. Holtzman DM
    (1998) Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest 101:1992–1999.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Clem RJ,
    2. Fechheimer M,
    3. Miller LK
    (1991) Prevention of apoptosis by a baculovirus gene during infection of insect cells. Science 254:1388–1390.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Colley NJ,
    2. Cassill JA,
    3. Baker EK,
    4. Zuker CS
    (1995) Defective intracellular transport is the molecular basis of rhodopsin-dependent dominant retinal degeneration. Proc Natl Acad Sci USA 92:3070–3074.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Davidson FF,
    2. Steller H
    (1998) Blocking apoptosis prevents blindness in Drosophila retinal degeneration mutants. Nature 391:587–591.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Dryja TD,
    2. McGee TL,
    3. Reichel E,
    4. Hohn LB,
    5. Cowley GS,
    6. Yandell DN,
    7. Sandberg MA,
    8. Berson EL
    (1990a) A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature 343:364–366.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Dryja TP,
    2. McGee TL,
    3. Hahn LB,
    4. Cowley GS,
    5. Olsson JE,
    6. Reichel E,
    7. Sandberg MA,
    8. Ma A,
    9. Berson EL
    (1990b) Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa. New Engl J Med 323:1302–1307.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Farrar GJ,
    2. McWilliam P,
    3. Bradley DG,
    4. Kenna P,
    5. Lawler M,
    6. Sharp EM,
    7. Humphries MM,
    8. Eiberg H,
    9. Conneally PM,
    10. Trofatter JA,
    11. Humphries P
    (1990) Autosomal dominant retinitis pigmentosa: linkage to rhodopsin and evidence for genetic heterogeneity. Genomics 8:35–40.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Farrar GJ,
    2. Kenna P,
    3. Jordan SA,
    4. Kumar-Singh R,
    5. Humphries MM,
    6. Sharp EM,
    7. Sheils DM,
    8. Humphries P
    (1991) A three-base-pair deletion in the peripherin-RDS gene in one form of retinitis pigmentosa. Nature 354:478–480.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Fernandes-Alnemri T,
    2. Litwack G,
    3. Alnemri ES
    (1994) CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 β-converting enzyme. J Biol Chem 269:30761–30764.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Fernandes-Alnemri T,
    2. Takahashi A,
    3. Armstrong R,
    4. Krebs J,
    5. Frits L,
    6. Tomaselli KJ,
    7. Wang L,
    8. Yu Z,
    9. Croce CM,
    10. Salveson G,
    11. Earnshaw WC,
    12. Litwack G,
    13. Alnemri ES
    (1995) Mch3, a novel apoptotic cysteine protease highly related to CPP32. Cancer Res 55:6045–6052.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Friesen PD,
    2. Miller LK
    (1987) Divergent transcription of early 35- and 94-kilodalton protein genes encoded by the HindIII K genome fragment of the baculovirus Autographa californica nuclear polyhedrosis virus. J Virol 61:2264–2272.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Gavrieli Y,
    2. Sherman Y,
    3. Ben-Sasson SA
    (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493–501.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Kajiwara K,
    2. Hahn LB,
    3. Mukai S,
    4. Travis GH,
    5. Berson EL,
    6. Dryja TP
    (1991) Mutations in the human retinal degeneration slow gene in autosomal dominant retinitis pigmentosa. Nature 354:480–483.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Kajiwara K,
    2. Berson EL,
    3. Dryja TP
    (1994) Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci. Science 264:1604–1608.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Kermer P,
    2. Klöcker N,
    3. Labes M,
    4. Bähr M
    (1998) Inhibition of CPP32-like proteases rescues axotomized retinal ganglion cells from secondary cell death in vivo. J Neurosci 18:4656–4662.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Kuida K,
    2. Zheng TS,
    3. Na S,
    4. Kuan C,
    5. Yang D,
    6. Karasuyama H,
    7. Rakic P,
    8. Flavell RA
    (1996) Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384:368–372.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Kurada P,
    2. O’Tousa JE
    (1995) Retinal degeneration caused by dominant mutations in Drosophila. Neuron 14:571–579.
    OpenUrlCrossRefPubMed
  22. ↵
    1. LaVail MM,
    2. Battelle B-A
    (1975) Influence of eye pigmentation and light deprivation on inherited retinal dystrophy in the rat. Exp Eye Res 21:167–192.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Margolin N,
    2. Raybuck SA,
    3. Wilson KP
    (1997) Substrate and inhibitor specificity of interleukin-1 beta-converting enzyme and related caspases. J Biol Chem 272:7223–7228.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. McLaughlin ME,
    2. Sandberg MA,
    3. Berson EL,
    4. Dryja TP
    (1993) Recessive mutations in the gene encoding the beta-subunit of rod phosphodiesterase in patients with retinitis pigmentosa. Nat Genet 4:130–134.
    OpenUrlCrossRefPubMed
  25. ↵
    1. McLaughlin ME,
    2. Ehrhart TL,
    3. Berson EL,
    4. Dryja TP
    (1995) Mutation spectrum of the gene encoding the beta subunit of rod phosphodiesterase among patients with autosomal recessive retinitis pigmentosa. Proc Natl Acad Sci USA 92:3249–3253.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Namura S,
    2. Zhu J,
    3. Fink K,
    4. Endres M,
    5. Srinivasan A,
    6. Tomaselli KJ,
    7. Yan J,
    8. Moskowitz MA
    (1998) Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neurosci 18:3659–3668.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Nicholson SW,
    2. Ali A,
    3. Thornberry NA,
    4. Vaillancourt JP,
    5. Ding CK,
    6. Gallant M,
    7. Gareau Y,
    8. Griffin PR,
    9. Labelle M,
    10. Lazebnik YA,
    11. Munday NA,
    12. Raju SM,
    13. Smulson ME,
    14. Yamin T-T,
    15. Yu YL,
    16. Miller DK
    (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37–43.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Olsson JE,
    2. Gordon JW,
    3. Pawlyk BS,
    4. Roof D,
    5. Hayes A,
    6. Molday RS,
    7. Mukai S,
    8. Cowley GS,
    9. Berson EL,
    10. Dryja TP
    (1992) Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa. Neuron 9:815–830.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Petters RM,
    2. Alexander CA,
    3. Wells KD,
    4. Collins EB,
    5. Sommer JR,
    6. Blanton MR,
    7. Rojas G,
    8. Hao Y,
    9. Flowers WL,
    10. Banin E,
    11. Cideciyan AV,
    12. Jacobson SG,
    13. Wong F
    (1997) Genetically engineered large animal model for studying cone photoreceptor survival and degeneration in retinitis pigmentosa. Nat Biotech 15:965–970.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Portera-Cailliau C,
    2. Sung C-H,
    3. Nathans J,
    4. Adler R
    (1994) Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc Natl Acad Sci USA 91:974–978.
    OpenUrlAbstract/FREE Full Text
  31. ↵
    1. Steele F,
    2. O’Tousa JE
    (1990) Rhodopsin activation causes retinal degeneration in Drosophila rdgC mutant. Neuron 4:883–890.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Steinberg RH,
    2. Flannery JG,
    3. Naash M,
    4. Oh P,
    5. Matthes MT,
    6. Yasumura D,
    7. Lau-Villacorta C,
    8. Chen J,
    9. LaVail MM
    (1996) Trangenic rat models of inherited retinal degeneration caused by mutant opsin genes. Invest Ophthalmol Vis Sci 37:S698.
    OpenUrl
  33. ↵
    1. Steinberg RH,
    2. Matthes MT,
    3. Yasumura D,
    4. Lau-Villacorta C,
    5. Nishikawa S,
    6. Cao W,
    7. Flannery JG,
    8. Naash M,
    9. Chen J,
    10. LaVail MM
    (1997) Slowing by survival factors of inherited retinal degenerations in transgenic rats with mutant opsin genes. Invest Ophthalmol Vis Sci 38:S226.
    OpenUrl
  34. ↵
    1. Tewari M,
    2. Quan LT,
    3. O’Rourke K,
    4. Desnoyers S,
    5. Zeng Z,
    6. Beidler DR,
    7. Poirier GG,
    8. Salvesen GS,
    9. Dixit VM
    (1995) Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81:801–809.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Thornberry NA,
    2. Lazebnik Y
    (1998) Caspases: enemies within. Science 281:1312–1316.
    OpenUrlAbstract/FREE Full Text
  36. ↵
    1. Travis GH,
    2. Brennan MB,
    3. Danielson PE,
    4. Kozak CA,
    5. Sutcliffe JG
    (1989) Identification of a photoreceptor-specific mRNA encoded by the gene responsible for retinal degeneration slow (rds). Nature 338:70–73.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Wyllie AH
    (1987) Apoptosis: cell death in tissue regulation. J Pathol 153:313–316.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Xue D,
    2. Horvitz HR
    (1995) Inhibition of the Caenorhabditis elegans cell death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein. Nature 377:248–251.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Yakovlev AG,
    2. Knoblach SM,
    3. Fan L,
    4. Fox GB,
    5. Goodnight R,
    6. Faden AI
    (1997) Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J Neurosci 17:7415–7424.
    OpenUrlAbstract/FREE Full Text
  40. ↵
    1. Yuan J,
    2. Shaham S,
    3. Ledoux S,
    4. Ellis HM,
    5. Horvitz HR
    (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75:641–652.
    OpenUrlCrossRefPubMed
Back to top

In this issue

The Journal of Neuroscience: 19 (12)
Journal of Neuroscience
Vol. 19, Issue 12
15 Jun 1999
  • Table of Contents
  • Index by author
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Activation of Caspase-3 in the Retina of Transgenic Rats with the Rhodopsin Mutation S334ter during Photoreceptor Degeneration
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Activation of Caspase-3 in the Retina of Transgenic Rats with the Rhodopsin Mutation S334ter during Photoreceptor Degeneration
Changdong Liu, Yiwen Li, Min Peng, Alan M. Laties, Rong Wen
Journal of Neuroscience 15 June 1999, 19 (12) 4778-4785; DOI: 10.1523/JNEUROSCI.19-12-04778.1999

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Activation of Caspase-3 in the Retina of Transgenic Rats with the Rhodopsin Mutation S334ter during Photoreceptor Degeneration
Changdong Liu, Yiwen Li, Min Peng, Alan M. Laties, Rong Wen
Journal of Neuroscience 15 June 1999, 19 (12) 4778-4785; DOI: 10.1523/JNEUROSCI.19-12-04778.1999
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • caspase-3
  • photoreceptors
  • Z-DEVD-FMK
  • rhodopsin mutation
  • degeneration
  • retina
  • transgenic rat

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • Scaffolding of Fyn Kinase to the NMDA Receptor Determines Brain Region Sensitivity to Ethanol
  • Cytoskeletal and Morphological Alterations Underlying Axonal Sprouting after Localized Transection of Cortical Neuron AxonsIn Vitro
  • Aberrant Chloride Transport Contributes to Anoxic/Ischemic White Matter Injury
Show more ARTICLE
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.